A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer
Titel:
A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer
Auteur:
Leighl, Natasha B. Burkes, Ronald L. Dancey, Janet E. Lopez, Pedro G. Higgins, Brian P. David Walde, P.L. Rudinskas, Leona C. Rahim, Yasmin H. Rodgers, Angela Pond, Gregory R. Shepherd, Frances A.